{"id":577,"date":"2017-02-27T18:34:55","date_gmt":"2017-02-27T23:34:55","guid":{"rendered":"https:\/\/www.bu.edu\/shipley\/?page_id=577"},"modified":"2017-03-26T20:08:26","modified_gmt":"2017-03-27T00:08:26","slug":"confirmmdx","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/shipley\/prostate-cancer-testing\/available-tests\/genetic-tests\/confirmmdx\/","title":{"rendered":"ConfirmMDX"},"content":{"rendered":"<p>     ConfirmMDX is a tissue-based gene assay that again helps stratify patients who are considering a repeat biopsy into those who may have a higher risk of recurrence. ConfirmMDX is not yet FDA approved but is in use as a supplement to traditional diagnostic such as a biopsy. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>ConfirmMDX is a tissue-based gene assay that again helps stratify patients who are considering a repeat biopsy into those who [&hellip;]<\/p>\n","protected":false},"author":6172,"featured_media":0,"parent":386,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"page-templates\/test.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/pages\/577"}],"collection":[{"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/users\/6172"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/comments?post=577"}],"version-history":[{"count":5,"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/pages\/577\/revisions"}],"predecessor-version":[{"id":926,"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/pages\/577\/revisions\/926"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/pages\/386"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/shipley\/wp-json\/wp\/v2\/media?parent=577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}